Trump Fires FDA Chief Makary Over Flavored Vape Dispute

President Trump has officially removed FDA Commissioner Marty Makary following a direct Oval Office confrontation over tobacco regulations. This sudden dismissal abruptly ends Makary’s tumultuous one-year tenure and highlights the administration’s aggressive push to align agency policies with its political priorities ahead of the midterm elections.

Makary’s ouster was primarily triggered by his resistance to internal efforts to approve fruit-flavored e-cigarettes. Although the FDA eventually reversed its stance last week, the delay and the resulting angry confrontation with the President proved fatal to his career in the West Wing.

The firing caught Makary and his staff by surprise, coming just 24 hours before he was scheduled to deliver high-stakes budget testimony to the Senate Appropriations Committee. Factions within the White House and the Department of Health and Human Services (HHS) had increasingly viewed his leadership as a source of policy confusion and constant staff turnover.

Beyond tobacco regulation, Makary faced an intense offensive from social conservatives. Anti-abortion groups recently met with White House officials to demand the reversal of regulations allowing the abortion pill mifepristone to be sent through the mail.

• Read more: FDA Approves First Fruit-Flavored Vapes for Adults Under Trump

Activists blamed Makary for his “indifference” toward nationwide prescribing rules for medication abortion, which accounts for roughly two-thirds of all U.S. abortions. The administration ultimately viewed resetting FDA leadership as a necessary step to satisfy this key political constituency.

Makary leaves behind a highly divisive legacy within the administration’s broader health coalition:

• Praise: He was commended by some factions for cracking down on ultraprocessed foods and artificial dyes.
• Criticism: He faced sharp attacks from vaccine skeptics for failing to pull Covid-19 immunizations, and from conservatives for his handling of medication abortion.

Makary’s exit exacerbates a growing leadership crisis within HHS. The administration currently lacks permanent leaders at the top of the FDA, the CDC, and the office of the Surgeon General.

The Senate now faces the challenging task of confirming a new FDA commissioner amid a crowded legislative calendar, as the administration seeks to repair relationships with the pharmaceutical industry and conservative voters before November.

• Read more: Trump Moves to Oust FDA Commissioner Over Flavored Vape Approvals
• News source: Trump fires FDA chief Makary after Oval Office clash over flavored vape approvals

• Author
• Recent Posts

Follow

Matthew Ma

Marketing at Ecigator

With over a decade of experience in the e-cigarette industry, Matthew Ma is a seasoned expert in both the manufacturing and usage aspects of vaping products. His extensive background has provided him with a deep understanding of the intricacies and evolving dynamics of e-cigarettes.

Follow

Latest posts by Matthew Ma (see all)

• FDA Memo: Fruit-Flavored Vapes No Better Than Tobacco for Quitting - June 12, 2026
• Macau Moves Closer to Total Public Vape Ban as New Bill Advances - June 11, 2026
• Can Smokeless Nicotine Alternatives Deliver a Smoke-Free World by 2040? - June 11, 2026

Related posts:

FDA Deploys AI and Slashes PMTA Review Times for Tobacco Products Rhode Island Senators Propose Lifting 2019 Ban on Flavored Vapes Newton City Council in Connecticut Approves Generational Tobacco Ban Illicit Vapes Seized in Scotland Rise 19.4% in 2024 Greece Mandates Digital Registry for Vape and Tobacco Sales Vaping Industry Faces Turmoil Under FDA and Trump